Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments

Novo Nordisk is a Danish pharmaceutical company.

Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments
Revenue(RF), mln.USD
159
Staff
574
Capital, mln.USD
140
Glob.Revenue, mln.USD
20005
The Company Statement

Suspend further marketing and clinical investment; pause new clinical trials and active enrollment

April 01, 2022https://www.novonordisk.com/news-and-media/critical-updates.html
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.